Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

BMRN BioMarin Pharmaceutical Inc

83,80

0,47 (0,56%)

03 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 5 - Annual statement of changes in beneficial ownership of securities

BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more BioMarin Pharmaceutical Charts.

BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more BioMarin Pharmaceutical Charts.

News BioMarin Pharmaceutical Inc

BioMarin Reports Record Financial Results for the First Quarter 2024
Mittwoch 24 April 2024 (1 Woche vor) • PR Newswire (US)

BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET
Mittwoch 10 April 2024 (3 Wochen vor) • PR Newswire (US)

New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
Dienstag 12 März 2024 (2 Monate vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
Donnerstag 7 März 2024 (2 Monate vor) • PR Newswire (US)

Form 144 - Report of proposed sale of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

BioMarin Scheduled to Participate in March Investor Conferences
Freitag 1 März 2024 (2 Monate vor) • PR Newswire (US)

Weitere BioMarin Pharmaceutical Inc News-Artikel

Gold vs US Dollar

Health Care Select Sector

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen